Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients

Ophélie Fourdinier, Eva Schepers, Valérie Metzinger-Le Meuth, Griet Glorieux, Sophie Liabeuf, Francis Verbeke, Raymond Vanholder, Benjamin Brigant, Anneleen Pletinck, Momar Diouf, Stéphane Burtey, Gabriel Choukroun, Ziad A. Massy, Laurent Metzinger* (Corresponding Author), Angel Argiles, Joachim Beige, Philippe Brunet, Gerald Cohen, Omar Abou Deif, Pieter EvenepoelDanilo Fliser, Ivo Fridolin, Andreas Gmerek, Joachim Jankowski, Vera Jankowski, Roos Masereeuw, Harald Mischak, Alberto Ortiz, Alessandra Perna, Juan Mariano Rodriguez-Portillo, Joost Schanstra, Goce Spasovski, Dimitrios Stamatialis, Sonja Steppan, Markus Storr, Bernd G. Stegmayr, Peter Stenvinkel, Paul J. Thornalley, Andrej Wiecek, on behalf of the European Uremic Toxin Work Group-EUTox

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

51 Citations (Scopus)
120 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience